Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, October 8, 2024.
Arcus Biosciences, Inc. (NYSE:RCUS)
Long-Term Uptrend (+90) - RCUS is in a strong uptrend that is likely to continue. While RCUS is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid RCUS?
MarketClub looks at technical strength and momentum to determine if the timing is right for RCUS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for RCUS
The long-term trend has been UP since Aug 20th, 2024 at 18.070
The intermediate-term trend has been UP since Oct 8th, 2024 at 18.015
The short-term trend has been UP since Oct 3rd, 2024 at 15.760
Smart Scan Analysis for RCUS
Based on our trend formula, RCUS is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 18.470 | 18.720 | 17.500 | 17.515 | +0.215 |
| Prev. Close | Volume | Bid | Ask | Time |
| 17.300 | 732972 | 2024-10-08 15:59:31 |
| Year High | 22.1 | Year High Date | 2018-03-15 |
| Year Low | 9.5 | Year Low Date | 2018-10-29 |
| 52wk High | 20.31 | 52wk High Date | 2024-02-27 |
| 52wk Low | 12.95 | 52wk Low Date | 2023-11-13 |
| Average Volume | 584,356 | Shares Outstanding | 91,428 |
| Market Cap | 426M | Assets | 118,600,000M |
| Liabilities | 551,000,000M | P/E Ratio | 14.725 |
| Volatility | 71.85 |